DuChemBIO Co.,Ltd. (KOSDAQ:176750)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Manufacturing and Sales of Radiopharmaceuticals and Related Medical Devices	35.60B	34.70B
Manufacturing and Sales of Radiopharmaceuticals and Related Medical Devices Growth	2.61%	-
Total	35.60B	34.70B
Total Growth	2.61%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
South Korea	35.56B	34.59B
South Korea Growth	2.79%	-
North America	5.37M	59.79M
North America Growth	-91.02%	-
Oceania	22.05M	13.28M
Oceania Growth	65.96%	-
Asia	18.09M	30.72M
Asia Growth	-41.11%	-
Total	35.60B	34.70B
Total Growth	2.61%	-

Source: S&P Global Market Intelligence.